- Home
- UUU vs ACON Comparison
UUU vs ACON Comparison
Compare UUU & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UUU | ACON |
|---|---|---|
| Founded | 1969 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6M | 4.4M |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | UUU | ACON |
|---|---|---|
| Price | $4.89 | $6.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $23.00 |
| AVG Volume (30 Days) | 37.9K | ★ 59.9K |
| Earning Date | 11-19-2025 | 11-12-2025 |
| Dividend Yield | ★ 21.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $16,346,015.00 | $67,483.00 |
| Revenue This Year | N/A | $145.39 |
| Revenue Next Year | N/A | $145.45 |
| P/E Ratio | $9.86 | ★ N/A |
| Revenue Growth | N/A | ★ 36.91 |
| 52 Week Low | $1.65 | $5.55 |
| 52 Week High | $8.27 | $3,499.49 |
Technical Indicators
Market Signals| Indicator | UUU | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 56.98 | 48.03 |
| Support Level | $4.00 | $5.71 |
| Resistance Level | $4.98 | $6.89 |
| Average True Range (ATR) | 0.28 | 0.61 |
| MACD | 0.11 | 0.06 |
| Stochastic Oscillator | 77.88 | 35.04 |
Price Performance
Historical ComparisonAbout UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.